Regular consumption of a beverage containing β-cryptoxanthin (b-Cx) and plant sterols (Ps) has been shown to exert a synergic effect in reducing cardiovascular risk and bone remodeling markers (formation and resorption). The present project aims to assess the influence of technological treatment and genetic variability on the bioavailability and the health effects of the added components (Ps, b-Cx), in particular to their potential role in prevalent disorders.In vitro and in vivo studies will be carried out to this effect. In vitro and in vivo studies (human intervention study) will be performed and cardiovascular, bone turnover and inflammation markers will be evaluated. Additionally, an in vitro colonic fermentation model and cell cultures will be used to explore anticarcinogenic effects and potential cytotoxicity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
40
Hospital Universitario Puerta de Hierro-Majadahonda
Majadahonda (Madrid), Madrid, Spain
serum response of B-cryptoxanthin
Time frame: 6 weeks of intervention
Serum response of phytosterols
Time frame: 6 weeks
Serum lipid profile
Time frame: 6 weks of intervention
bone resorption markers
Time frame: 6 weeks
interleukins
Time frame: 6 weeks
Serum C-reactive protein
Time frame: 6 weeks
Bone formation markers
Time frame: 6 weeks
Sterols faecal levels
Time frame: 6 weeks
Erythrocytes for eryptosis evaluation
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.